COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Androgens for Poor Responders in In Vitro Fertilization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00693108
Recruitment Status : Completed
First Posted : June 6, 2008
Last Update Posted : June 6, 2008
Information provided by:
Hospital Clinic of Barcelona

Brief Summary:
it has been shown that androgens in non human primates may favour follicular growth in the ovaries when animals are treated with gonadotropins which are the hormones used in patients receiving treatment with in vitro fertilization. Therefore, this study investigates the potential usefulness of testosterone treatment preceding gonadotropin administration in in vitro fertilization patients having a previous poor response to gonadotropins alone.

Condition or disease Intervention/treatment Phase
Ovarian Response Drug: Transdermal testosterone Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Official Title: Transdermal Testosterone to Improve Ovarian Response to Gonadotropins in Poor Responder IVF Patients With Normal Basal Concentrations of FSH
Study Start Date : September 2006

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: 1
Transdermal testosterone treatment during the five days preceding gonadotropin therapy in IVF cycles
Drug: Transdermal testosterone
No Intervention: 2

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   19 Years to 39 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients receiving the second IVF treatment attempt having the first treatment cycle cancelled because of poor ovarian response to gonadotropins

Exclusion Criteria:

  • Previous ovarian surgery
  • Clinical or laboratory profile suggesting premature ovarian failure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00693108

Layout table for location information
Hospital Clinic
Barcelona, Spain, 08036
Sponsors and Collaborators
Hospital Clinic of Barcelona
Layout table for additonal information Identifier: NCT00693108    
Other Study ID Numbers: IVFANDROGENS
First Posted: June 6, 2008    Key Record Dates
Last Update Posted: June 6, 2008
Last Verified: June 2008
Keywords provided by Hospital Clinic of Barcelona:
Additional relevant MeSH terms:
Layout table for MeSH terms
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs